Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | FABP7 | O15540 | 1/20 | 0.36 |
| ▸ | FABP3 | P05413 | 1/20 | 0.36 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3843330 | 0.97 | HTT (0.39) | CA12CA1CA2CA4CA7 | |
| SCHEMBL3847171 | 0.86 | ALDH1A1 (0.52) | HTTALDH1A1MAPK1L3MBTL1TSHR | |
| SCHEMBL5542746 | 0.85 | FABP7 (0.31) | IDO1FABP7FABP3FABP5 | |
| SCHEMBL1861362 | 0.85 | KDM4E (0.52) | IDO1FABP7FABP3FABP5ALDH1A1 | |
| SCHEMBL20222287 | 0.85 | ALDH1A1 (0.38) | HTTALDH1A1MAPK1L3MBTL1TSHR | |
| SCHEMBL3605816 | 0.85 | CXCL8 (0.50) | ALDH1A1L3MBTL1CXCL8SLC6A2SLC6A4 | |
| SCHEMBL1861335 | 0.85 | TSHR (0.52) | ALDH1A1TSHRSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1862821 | 0.85 | CXCL8 (0.50) | HTTALDH1A1TSHRCXCL8SLC6A2 | |
| SCHEMBL18508315 | 0.85 | — | — | |
| SCHEMBL3843817 | 0.84 | ALDH1A1 (0.50) | CA1CA2HTTALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4563569-A1 | AMIDE COMPOUND CONTAINING IODO ARYL OR IODO HETEROARYL, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd. (CN) | 2025-06-04 | — | — | EP | disclosed |
| US-12297311-B2 | Biaryl hydroxythiophene group IV transition metal polymerization with chain transfer capability | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-05-13 | — | — | US | disclosed |
| US-12221508-B2 | Biaryl phenoxy group IV transition metal catalysts for olefin polymerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-02-11 | — | — | US | disclosed |
| EP-3642250-B1 | BIARYL PHENOXY GROUP IV TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-12-18 | — | — | EP | disclosed |
| US-12122862-B2 | Biaryl hydroxythiophene group IV transition metal polymerization catalysts with chain transfer capability | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-10-22 | — | — | US | disclosed |
| US-20240327335-A1 | AMIDE COMPOUND HAVING IODOARYL OR IODOHETEROARYL, PREPARATION METHOD THEREFOR AND USE THEREOF | CARDIOLINK SCIENCE (SHENZHEN) MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD. (CN) | 2024-10-03 | — | — | US | disclosed |
| WO-2024040745-A1 | AMIDE COMPOUND CONTAINING IODO ARYL OR IODO HETEROARYL, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 科睿驰（深圳）医疗科技发展有限公司 | 2024-02-29 | — | — | WO | disclosed |
| CN-110809586-B | Biaryl phenoxy group IV transition metal catalysts for olefin polymerization | 陶氏环球技术有限责任公司 | 2023-06-27 | — | — | CN | disclosed |
| US-20230200206-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230200206-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-5531979-A | X-RAY CONTRAST COMPOSITION | STERLING WINTHROP INC. (US) | 1996-07-02 | — | — | US | disclosed |
| US-5531979-A | X-RAY CONTRAST COMPOSITION | STERLING WINTHROP INC. (US) | 1996-07-02 | — | — | US | disclosed |
| EP-0609587-A3 | Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract. | STERLING WINTHROP INC (US) | 1995-09-06 | — | — | EP | disclosed |
| EP-0609586-A3 | Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract. | STERLING WINTHROP INC (US) | 1995-09-06 | — | — | EP | disclosed |
| EP-0609586-A2 | Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract | NYCOMED IMAGING AS (NO) | 1994-08-10 | — | — | EP | disclosed |
| EP-0609587-A2 | Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract | NYCOMED IMAGING AS (NO) | 1994-08-10 | — | — | EP | disclosed |
| US-5326553-A | Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract | STERLING WINTHROP INC. (US) | 1994-07-05 | — | — | US | disclosed |
| US-5316755-A | AQUEOUS X-RAY CONTRAST COMPOSITION FOR ORAL OR RECTAL ADMINISTRATION | STERLING WINTHROP INC. (US) | 1994-05-31 | — | — | US | disclosed |
| US-5250657-A | Process for preparing polyarylene thioether | SEISAN KAIHATSU KAGAKU KENKYUSHO (JP) | 1993-10-05 | — | — | US | disclosed |
| EP-0440106-A2 | Process for preparing polyarylene thioethers | SEISAN KAIHATSU KAGAKU KENKYUSHO (JP) | 1991-08-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240327335-A1 | AMIDE COMPOUND HAVING IODOARYL OR IODOHETEROARYL, PREPARATION METHOD THEREFOR AND USE THEREOF | WEE1, WEE2, WASF2 | CA12 2798/4885CA1 3449/4885CA2 4727/4885 |
| US-12122862-B2 | Biaryl hydroxythiophene group IV transition metal polymerization catalysts with chain transfer capability | TRMT1, GFPT1, BCAT1 | CA12 3043/4885CA1 4125/4885CA2 2781/4885 |
| US-20230200206-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | MCM4, MCM2, CCNL2 | CA12 980/4885CA1 943/4885CA2 1999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.